Venous Admixture in COPD: Pathophysiology and Therapeutic Approaches by Cooper, Christopher B. & Celli, Bartolome
COPD: Journal of Chronic Obstructive Pulmonary Disease, 5:376–381
ISSN: 1541-2555 print / 1541-2563 online
Copyright c   2008 Informa Healthcare USA, Inc.
DOI: 10.1080/15412550802522783
PERSPECTIVES
Venous Admixture in COPD: Pathophysiology and
Therapeutic Approaches
Christopher B. Cooper1 (ccooper@mednet.ucla.edu) and Bartolome Celli2 (bcelli@copdnet.org)
1David Geffen School of Medicine, University of California, Los Angeles, California, USA
2Caritas St Elizabeth’s Medical Center, Tufts University, Boston, Massachusetts, USA
ABSTRACT
Chronic obstructive and interstitial lung diseases impair pulmonary gas exchange leading
to wasted ventilation (alveolar dead space) and wasted perfusion (venous admixture). These
two fundamental types of abnormality represent opposite ends of the spectrum of ventilation-
perfusion mismatch with ˙ V/ ˙ Q ratios of inﬁnity and zero. Treatment approaches that improve
airway function, reduce air trapping and hyperinﬂation have received much attention and might
be successful at ameliorating the problems associated with high ˙ V/ ˙ Q.H owever, in patients
with low ˙ V/ ˙ Q abnormality in whom venous admixture leads to hypoxemia, there are few ther-
apeutic options. Indeed, some patients are refractory to treatment with supplemental oxygen
particularly during exercise. Theoretically these patients could beneﬁt from an intervention that
increased mixed venous oxygen content thereby ameliorating the deleterious effects of venous
admixture. In this perspective article we discuss the mechanisms whereby venous admixture
contributes to hypoxemia and reduced oxygen delivery to tissues. We explore methods which
could potentially increase mixed venous oxygen content thus ameliorating the deleterious ef-
fects of venous admixture. One such intervention that warrants further investigation is the
therapeutic creation of an arterio-venous ﬁstula. Such an approach would be novel, simple and
minimally invasive. There is reason to believe that complications would be minor leading to
af avorable risk-beneﬁt analysis. This approach to treatment could have signiﬁcant impact for
patients with COPD but should also beneﬁt any patient with chronic hypoxemia that impairs
exercise performance.
INTRODUCTION
Chronicpulmonarydiseases,bothobstructiveandrestrictive,
impose mechanical constraints on pulmonary ventilation but
also disrupt gas exchange through a variety of complex mecha-
nisms (1). Pulmonary gas exchange is crucial for oxygen uptake
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and carbon dioxide elimination and must be adjusted to match
the varying metabolic demands of the body (2).
Gas exchange relies upon efﬁcient matching of ventilation
with perfusion in the lungs (3). An ideal ventilation-perfusion
( ˙ V/ ˙ Q)ratioexistswithanumericalvalueof0.8whenventilation
and perfusion are expressed in like units (e.g., L/min). ˙ V/ ˙ Q can
be considered for the respiratory system as a whole or in terms
of many individual lung units each of which could be regarded
conceptually as an alveolus and its pulmonary capillaries. An
ideallungwouldhaveauniformdistributionof ˙ V/ ˙ Q withvalues
close to 0.8. In reality this does not happen and a spectrum
of ˙ V/ ˙ Q exists from zero to inﬁnity. In normal subjects, the
main factor that affects ˙ V/ ˙ Q is gravity resulting, in the upright
posture, in a gradient from high values at the lung apices to low
values at the lung bases.
In patients with chronic pulmonary disease it is the patho-
logical destruction of the lung parenchyma that disrupts ˙ V/ ˙ Q
and since the pathology is often unevenly distributed through-
out the lungs, the ˙ V/ ˙ Q mismatch is said to be heterogeneous.
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perfusion. In these circumstances ˙ V/ ˙ Qi shigh and a proportion
of the ventilation can be considered as “wasted”. Areas of the
lung that are ventilated but receive no perfusion have a ˙ V/ ˙ Q ra-
tio of inﬁnity. Other areas of the lung could be under-ventilated
relative to perfusion. In these circumstances ˙ V/ ˙ Qi slow and a
proportion of the perfusion can be considered to be “wasted”.
Areas of the lung that are perfused but receive no ventilation
have a ˙ V/ ˙ Q ratio of zero.
In summary, there are essentially two types of gas exchange
abnormality—high ˙ V/ ˙ Q and low ˙ V/ ˙ Q. High ˙ V/ ˙ Q increases
alveolar dead space thus increasing the ventilatory requirement
atagivenmetabolicrateandaffectingthecompositionofmixed
expired gas. Low ˙ V/ ˙ Q results in a phenomenon called venous
admixture or physiological shunt, whereby poorly oxygenated
bloodpassesthroughthelungsandmixeswiththeblooddraining
into the left atrium, which will eventually be delivered to the
systemic circulation via contraction of the left ventricle (4). The
deﬁcit in systemic arterial oxygen content (hypoxemia) which
results from venous admixture worsens with increased blood
ﬂow through areas of low ˙ V/ ˙ Q as can be seen with increases in
cardiac output during exercise.
Theoretical impact of venous admixture on
arterial oxygenation
The impact of venous admixture on arterial oxygenation can
be understood by considering the classical equation used to cal-
culate physiological shunt:
CaO2 · ˙ QT = C¯ vO2 · QS + Cpc O2 · ˙ QP
where ˙ QT istotalpulmonarybloodﬂow, ˙ QS ispulmonaryshunt
or venous admixture, ˙ QP is the remainder of the pulmonary
blood ﬂow and Cpc O2 is the end-pulmonary capillary oxygen
content.
Alternatively
CaO2 = C¯ vO2 ·
˙ QS
˙ QT
+ Cpc O2 ·
˙ QP
˙ QT
but since
˙ QP
˙ QT
= 1 −
˙ QS
˙ QT
then
CaO2 = C¯ vO2
˙ QS
˙ QT
+ Cpc O2 ·
 
1 −
˙ QS
˙ QT
 
or
CaO2 =
˙ QS
˙ QT
(C¯ vO2 − Cpc O2) + Cpc O2
This equation has been used in Figure 1a and 1b to de-
rive CaO2 for different values of
˙ QS
˙ QT and C¯ vO2 assuming that
Cpc O2 is0.20L/L.Fromthesecalculationsonecandeducethat
forapulmonaryshuntfractionorvenousadmixturethatequates
to 20% of the cardiac output, CaO2 would decrease by 0.002
L/L (0.2 ml/dl) for a decrease in C¯ vO2 of 0.01 L/L (1 ml/dl).
The role of oxygenation in exercise limitation
Exercise physiology is a complex subject but practical
approaches have increased our understanding (5). With the
performance of external work there is an obligatory require-
ment for energy to facilitate muscle contraction. Ideally, under
aerobicconditions,whenoxygenisinplentifulsupply,increases
in external work are match by increases in oxygen uptake. The
presence of sufﬁcient oxygen allows complete combustion of
metabolic substrate with the generation or regeneration of ATP
from oxidative phosphorylation. Hence, it is the contracting
muscle that dictates the oxygen uptake required for the per-
formance of exercise (6).
The circulation plays a role in transporting oxygen from the
lungs to skeletal muscles and oxygen delivery to tissues can be
calculated by the following formula:
DO2 = ˙ QC · CaO2
where DO2 is oxygen delivery in L/min, ˙ QC is cardiac output
also in L/min and CaO2 is arterial oxygen content in liters of
oxygen per liter of blood.
Given the simplicity of this formula it can be seen that ˙ QC
and CaO2 are equally important determinants of DO2. Cardiac
output would seem to be important in adjusting oxygen deliv-
ery during exercise. However, patients with mild to moderate
chronic pulmonary disease do not have difﬁculty increasing ˙ QC
onexertion(7)andevenpatientswithseverehyperinﬂationmay
havenormalhemodynamics(8).Ontheotherhand,patientswith
severe COPD associated with marked airﬂow obstruction, hy-
perinﬂationandincreasedworkofbreathingexhibitlargeswings
in intrathoracic pressure during the breathing cycle that could
adversely impact cardiac function (9). Despite these consid-
erations, it seems likely that these patients will have greater
difﬁculty maintaining arterial oxygen content than cardiac
output.
The importance of CaO2 is not simply as a determinant of
oxygen delivery by blood ﬂow but also in maintaining an ad-
equate oxygen diffusion gradient in the tissues. At rest, CaO2
is 0.20 L/L (20 ml/dl) compared with mixed venous oxygen
content (C¯ vO2) that is 0.15 L/L (15 ml/dl). Hence, only about
25% of the oxygen available in arterial blood is extracted by
the tissues. During exercise CaO2 does not normally change but
C¯ vO2 can fall as low as 0.05 L/L (5 ml/dl) reﬂecting increased
oxygen extraction by exercising muscles. Interestingly, it is not
simply the oxygen delivery that is important in providing oxy-
gentoexercisingmusclebutthefactthatacriticaloxygenpartial
pressure can be sustained in the muscle capillaries. This criti-
cal capillary oxygen partial pressure (Pmc O2)i sthe necessary
driving pressure for oxygen diffusion from the muscle capillary
to the mitochondrion. Pmc O2 is thought to be approximately
20 mm Hg whereas the mitochondrial oxygen partial pressure
is only about 1 mm Hg (10). While the muscle capillary oxy-
genpartialpressureisclearlyinﬂuencedbyoxygendeliveryand
oxygen utilization in the muscle, it is also crucially dependent
on CaO2. One can easily envisage a situation where ˙ QC and
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Figure 1. Theoretical calculations based on the classical shunt equation: (a) Effect of venous admixture or pulmonary shunt fraction ( ˙ QS/ ˙ QT)
on arterial oxygen content (CaO2)f or a given mixed venous oxygen content (C ¯ vO 2) assuming ideal pulmonary capillary oxygen content is 0.20
L/L; (b) effect of C ¯ vO 2 on CaO2 for a given ˙ QS/ ˙ QT also assuming ideal pulmonary capillary oxygen content is 0.20 L/L; and (c) effect of an
arteriovenous stula expressed as a fraction of cardiac output ( ˙ QF/ ˙ QT)o nC ¯ vO 2 for a given CaO2 assuming systemic capillary oxygen content
is 0.15 L/L.
muscle blood ﬂow are increased but because of a low CaO2, the
Pc O2 cannot be maintained.
Let us then consider the pathologies that affect the provision
of oxygen to skeletal muscle. Firstly, there is cardiac failure
resulting in low ˙ QC. DO2 is reduced in direct proportion to the
reduced ˙ QC;h owever, typically, in this setting, tissue oxygen
extractionproceedsresultinginalowerC¯ vO2.ProvidedCaO2 is
adequate,and ˙ QC isnotextremelylow,itshouldstillbepossible
to maintain the Pmc O2.
Hemoglobinconcentrationisanotherfactorwhichinﬂuences
CaO2 because CaO2 is calculated as the sum of the oxygen
combined with hemoglobin and that dissolved in the plasma.
The formula that determines CaO2 is as follows (11):
CaO2 = [Hb] · 1.34 · SaO2 + PaO2 · 0.0031
where CaO2 is arterial oxygen content in ml of oxygen per
deciliter of blood, SaO2 is the percentage oxyhemoglobin satu-
ration, [Hb] is hemoglobin concentration in g/dl, PaO2 is the
arterial oxygen partial pressure in mm Hg.
Thisformulashowsthatinanemia,areductionofhemoglobin
concentration of 1 g/dl will result in approximate 6–7% reduc-
tion in arterial oxygen content. The importance of this obser-
vation in patients with chronic pulmonary disease is unknown
but many of these patients have anemia or relative anemia
378 December 2008 COPD: Journal of Chronic Obstructive Pulmonary Disease(12) and anemia adversely affects exercise capacity in COPD
(13).
Venous admixture is arguably a much more serious consid-
eration in terms of providing oxygen to skeletal muscle. To the
extent that venous admixture lowers CaO2 it will also reduce
the driving pressure for oxygen diffusion in the tissues and in
these circumstances it might not be possible to maintain the
Pmc O2.Interestingly,incircumstancesofskeletalmuscledys-
functionwherethemuscleisunabletoutilizeoxygenbecauseof
structuralormetabolicabnormalities,thenC¯ vO2 mightactually
be higher than normal (14).
Hence,thecomplexpathophysiologywhichoccursinchronic
pulmonary diseases can impair exercise performance in several
ways. Increased ventilatory requirement for a given level of ex-
ercise,causesdyspneaand,insomecases,ventilatorylimitation
(15). Hypoxemia reduces oxygen delivery to skeletal muscles
as well as markedly worsening dyspnea through carotid body
stimulation.
Approaches to improving exercise
performance in chronic obstructive pulmonary
disease
Chronicobstructivepulmonarydisease(COPD)isaprogres-
sive disease that encompasses chronic bronchitis and emphy-
sema (16). COPD is the most common chronic pulmonary dis-
ease worldwide and is thought to affect 24 million Americans
(17).About2–3millionofthesearelikelytohaveseveredisease
withsigniﬁcanthypoxemiaandexerciseimpairment.Themech-
anismsofexerciselimitationdescribedabovearehighlyrelevant
to patients with severe COPD. They have reduced aerobic ca-
pacity, deconditioning, increased ventilatory requirement and
chronic hypoxemia that predictably worsens with exertion (18).
When these patients reach this stage of disease severity their
therapeutic options are limited. Nevertheless, there has been
considerable progress in recent years in developing approaches
to improve exercise performance in patients with chronic pul-
monary diseases, particularly in COPD (19).
Inhaledbronchodilatortherapyisregardedasimportantinthe
maintenance treatment of COPD because of the demonstrated
beneﬁts on dyspnea, exercise performance and quality of life.
Studies of long-acting bronchodilators indicate that these bene-
ﬁts relate to reduced static and dynamic hyperinﬂation (20–22).
Phenotypically, therefore, the type of patient who beneﬁts from
bronchodilator therapy, at least in terms of reducing lung vol-
ume, has emphysematous destruction of the lung parenchyma
and a component of high ˙ V/ ˙ Q abnormality.
Even in patients with severe chronic pulmonary diseases,
physicalreconditioningcanbeachievedthroughstructuredexer-
cise training programs (23). These programs reduce lactic acid
accumulation and hence reduce ventilatory requirement for a
given level of exercise (24). They also improve breathing efﬁ-
ciency, regardless of the reconditioning effect and this beneﬁt
probably relates to slowed breathing frequency (25).
Patients who demonstrate hypoxemia during exercise show
improvedexerciseperformancewithsupplementaloxygen(26).
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Figure 2. Effect of supplemental oxygen on ventilation-perfusion
mismatch (low ˙ V/ ˙ Q) and intra-pulmonary shunt ( ˙ V/ ˙ Q =0). When
breathing 100% oxygen from a closed circuit (FIO2 100%), even
lung regions with very low alveolar ventilation (on the left) should
see an increase in alveolar oxygen tension (PAO2) to greater then
100 mm Hg in which case the blood draining that region will be
fully saturated. By contrast, regions of intra-pulmonary shunt (on
the right) experience no ventilation and the blood draining those
regions has an oxygen content equal to the mixed venous blood
(C ¯ vO 2).
An obvious mechanism for this beneﬁt would be correction of
the hypoxemia but a secondary improvement in breathing me-
chanics might also occur due to reduced breathing frequency
from suppression of carotid body activity (27).
Supplementaloxygenisconsideredeffectiveatcorrectingthe
hypoxemia that results from ˙ V/ ˙ Q mismatch in the lungs. The
rationale is shown in Figure 2.
Bysubstantiallyincreasingtheinspiredoxygenconcentration
and partial pressure, it is believed that even areas of low ˙ V/ ˙ Q
that have low levels of ventilation will experience a sufﬁcient
increase in alveolar oxygen partial pressure (>100 mm Hg) to
fully oxygenate the blood in the adjacent pulmonary capillaries.
Thiswillreducebutnotabolishvenousadmixturebecauseareas
with no ventilation ( ˙ V/ ˙ Q = 0) will not be inﬂuenced by the
inspired oxygen concentration.
To the extent that a patient with chronic pulmonary disease
has increased physiological shunt, that patient will be refractory
to the beneﬁts from supplemental oxygen. These pathophysio-
logical effects are seen in many types of lung disease but partic-
ularly in patients with COPD (18) and pulmonary ﬁbrosis (28).
Mechanisms to reduce the adverse
consequences of venous admixture
Venous admixture becomes extremely relevant as a cause of
hypoxemia in patients with chronic pulmonary diseases, partic-
ularlyduringexercisewhencardiacoutputisincreasedandﬂow
through areas of intra-pulmonary shunt is increased. Further-
more, as noted above, supplemental oxygen only beneﬁts areas
of ˙ V/ ˙ Q mismatch and patients with extensive intra-pulmonary
shunt may actually be refractory to this treatment. Elevation
of C¯ vO2 should ameliorate the deleterious effects of venous
COPD: Journal of Chronic Obstructive Pulmonary Disease December 2008 379admixture both at rest and also, importantly during exercise. In
therapeutic terms there are few ways to increase C¯ vO2.
Onesimplemethodwouldbetoincrease[Hb]bybloodtrans-
fusionorstimulationoferythropoesis.Autotransfusionofblood
in athletes (blood doping) is well know to enhance aerobic per-
formance although in the context of an athlete the mechanisms
are probably somewhat different (29). Improved exercise per-
formance related to increased red cell mass can also achieved in
athletes by stimulation of erythropoesis with hypobaric hypoxia
(altitude)(30).Humanerythropoietinoritsanalogueshavebeen
considered but concerns exist as to what is an appropriate [Hb]
in a patient with chronic hypoxemia and what is the risk of in-
travascular thrombosis due to increased blood viscosity (31).
The cost of these agents is also likely to be a limiting factor.
A more intriguing method by which to increase C¯ vO2 is the
therapeutic creation of an arterio-venous (AV) ﬁstula. This ap-
proachwouldshuntoxygenatedarterialbloodfromthesystemic
arterial circulation to the systemic veins thus directly inﬂuenc-
ing and increasing C¯ vO2. There has been extensive previous
experience of artiﬁcially created AV ﬁstulae in the context of
renal failure patients needing hemodialysis (32). A theoretical
advantage of the therapeutic AV ﬁstula is that it should improve
hypoxemia not only in patients with ˙ V/ ˙ Q mismatch but also
those with increased physiological shunt who are refractory to
treatment with supplemental oxygen.
The effect of an arteriovenous ﬁstula on C¯ vO2 can be ex-
plored theoretically with an equation analogous to that used for
thecalculationofCaO2 takingintoaccountphysiologicalshunt:
C¯ vO2 · ˙ QT = CaO2 · QF + Csc O2 · ˙ QNF
where ˙ QT is total systemic blood ﬂow, ˙ QF is the blood ﬂow
through the ﬁstula, ˙ QNF is the remainder of the systemic blood
ﬂowandCsc O2 isthemixedsystemiccapillaryoxygencontent.
Alternatively
C¯ vO2 = CaO2 ·
˙ QF
˙ QT
+ Csc O2 ·
˙ QNF
˙ QT
but since
˙ QNF
˙ QT
= 1 −
˙ QF
˙ QT
then
C¯ vO2 = CaO2 ·
˙ QF
˙ QT
+ Csc O2 ·
 
1 −
˙ QF
˙ QT
 
or
C¯ vO2 =
˙ QF
˙ QT
(CaO2 − Csc O2) + Csc O2
This equation has been used in Figure 1c to derive C¯ vO2 for
different values of
˙ QF
˙ QT and CaO2 assuming that Csc O2 is 0.15
L/L. From these calculations one can deduce that for a CaO2
of 0.18 L/L (18 ml/dl or ≈90% saturation), an increase in ﬂow
through the ﬁstula of 0.1 (10% of total systemic blood ﬂow)
would increase C¯ vO2 by 0.003 L/L (0.3 ml/dL).
AnyCOPDpatientwithhypoxemia,eitherchronicallyatrest
or intermittently during exercise, would be expected to have a
range of low ˙ V/ ˙ Q abnormalities in the lungs. In these patients,
the component of “ ˙ V/ ˙ Q mismatch” or low ˙ V/ ˙ Q would be ex-
pected to improve, at least to some extent, with supplemental
oxygen. The same patients would most likely have a degree
of venous admixture which would be refractory to supplemen-
tal oxygen but could potentially be improved by creation of an
arterio-venous ﬁstula that elevates C¯ vO2.
Potential adverse consequences of an
arterio-venous ﬁstula
Peripheralarterio-venousﬁstulaeorshuntsrepresentareduc-
tioninsystemicvascularresistanceandthereforetendtobeasso-
ciated with an increased cardiac output. The question obviously
arises as to how this would be tolerated over time. Furthermore,
patients with chronic pulmonary disease might already be expe-
riencing right ventricular compromise from increased afterload
due to hypoxic pulmonary vasoconstriction or pulmonary vas-
cular remodeling. An increased ˙ QC could worsen this situation
and lead to further increases in pulmonary arterial pressures.
On the other hand, if the elevation of C¯ vO2 contributed to an
improvement of oxygenation within the lung there could be a
reduction in hypoxic pulmonary vasoconstriction, reduction in
pulmonaryvascularresistanceandparadoxicalreductioninpul-
monaryarterialpressuresdespitetheincreased ˙ QC.Preliminary
data from patients with severe COPD suggest that these effects
can occur (33).
Another concern would be that creation of an AV ﬁstula
woulddivertsomeofthearterialbloodﬂowtothatlimbresulting
in a relative deprivation of oxygen delivery. Whilst theoretically
possible,itisalsolikelythatlocalautoregulationwouldpreserve
the arterial blood ﬂow distal to the ﬁstula and that the increased
˙ QC is in part a reﬂection of this adaptation.
SUMMARY
Patients with chronic pulmonary disease that have disrupted
gas exchange which increases physiological shunt and venous
admixture. These patients have serious problems with oxygena-
tionandareoftensomewhatrefractorytotreatmentwithsupple-
mental oxygen particularly during exercise. Theoretically they
could beneﬁt from an intervention that increased mixed venous
oxygen content thereby ameliorating the deleterious effects of
venous admixture.
One such intervention that warrants further investigation is
the therapeutic creation of an arterio-venous ﬁstula. Such an
approach would be novel, simple and minimally invasive. There
is reason to believe that complications would be minor leading
to a favorable risk-beneﬁt analysis. This approach to treatment
couldhavesigniﬁcantimpactforpatientswithCOPDbutshould
also beneﬁt any patient with chronic hypoxemia that impairs
exercise performance.
REFERENCES
1. Cooper CB. Determining the role of exercise in patients with
chronic pulmonary disease. Med Sci Sports Exerc 1995;27:147—
157.
380 December 2008 COPD: Journal of Chronic Obstructive Pulmonary Disease2. Astrand P-O, Rodahl K. Textbook of work physiology: McGraw-
Hill, 1970.
3. West JB. Ventilation/blood o w and gas exchange. 4th ed. Oxford:
Blackwell Scienti c Publications, 1985.
4. Wagner PD. Ventilation/perfusion relationships. Clin Physiol
1981;1:437—451.
5. Cooper CB, Storer TW. Exercise Testing and Interpretation: A
Practical Approach. New York: Cambridge University Press, 2001.
6. Wagner PD. New ideas on limitations to VO2max. Exerc Sport Sci
Rev 2000;28:10—14.
7. Spiro SG, Hahn HL, Edwards RH, et al. An analysis of the phys-
iological strain of submaximal exercise in patients with chronic ob-
structive bronchitis. Thorax 1975;30:415—425.
8. MarchettiN,PanettaN,CrinerG.Theeffectoflunghyperin ation
inCOPDoncardiacfunction.ProcAmThoracSoc2008;177:A782.
9. Montes de Oca M, Rassulo J, Celli BR. Respiratory muscle and
cardiopulmonary function during exercise in very severe COPD.
Am J Respir Crit Care Med 1996;154:1284—1289.
10. Wagner PD. Diffusive resistance to O2 transport in muscle. Acta
Physiol Scand 2000;168:609—614.
11. Severinghaus JW. Simple, accurate equations for human blood
O2 dissociation computations. J Appl Physiol 1979;46:599—602.
12. John M, Lange A, Hoernig S, et al. Prevalence of anemia
in chronic obstructive pulmonary disease: comparison to other
chronic diseases. Int J Cardiol 2006;111:365—370.
13. Cote C, Zilberberg MD, Mody SH, et al. Haemoglobin level and
its clinical impact in a cohort of patients with COPD. Eur Respir J
2007;29:923—929.
14. Moore GE, Parsons DB, Stray-Gundersen J, et al. Uremic my-
opathy limits aerobic capacity in hemodialysis patients. Am J Kid-
ney Dis 1993;22:277—287.
15. Cooper CB. Exercise in chronic pulmonary disease: aerobic ex-
ercise prescription. Med Sci Sports Exerc 2001;33:S671—679.
16. Fabbri L, Pauwels RA, Hurd SS. Global strategy for the diag-
nosis, management, and prevention of chronic obstructive pul-
monarydisease:GOLDExecutiveSummaryupdated2003.COPD
2004;1:105—141;discussion 103—104.
17. Mannino DM, Homa DM, Akinbami LJ, et al. Chronic obstruc-
tive pulmonary disease surveillance United States, 1971—2000.
MMWR Surveill Summ 2002;51:1—16.
18. Cooper CB. The connection between chronic obstructive pul-
monary disease symptoms and hyperin ation and its impact on
exercise and function. Am J Med 2006;119:21—31.
19. Casaburi R, Petty TL. Principles and practice of pulmonary reha-
bilitation. Philadelphia: WB Saunders Company, 1993.
20. CelliB,ZuWallackR,WangS,etal.Improvementin resting inspi-
ratory capacity and hyperin ation with tiotropium in COPD patients
with increased static lung volumes. Chest 2003;124:1743—1748.
21. O’Donnell DE, Fluge T, Gerken F, et al. Effects of tiotropium on
lunghyperin ation, dyspnoeaandexercisetoleranceinCOPD.Eur
Respir J 2004;23:832—840.
22. O’Donnell DE, Voduc N, Fitzpatrick M, et al. Effect of salme-
terol on the ventilatory response to exercise in chronic obstructive
pulmonary disease. Eur Respir J 2004;24:86—94.
23. Nici L, Donner C, Wouters E, et al. American Thoracic So-
ciety/European Respiratory Society statement on pulmonary
rehabilitation. Am J Respir Crit Care Med 2006;173:1390—
1413.
24. Casaburi R, Patessio A, Ioli F, et al. Reductions in exercise lactic
acidosis and ventilation as a result of exercise training in patients
with obstructive lung disease. Am Rev Respir Dis 1991;143:9—
18.
25. Casaburi R, Porszasz J, Burns MR, et al. Physiologic bene-
ts of exercise training in rehabilitation of patients with severe
chronicobstructivepulmonarydisease.AmJRespirCritCareMed
1997;155:1541—1551.
26. Cooper CB. Long-term oxygen therapy. In: Casaburi R, Petty TL,
eds. Principles and practice of pulmonary rehabilitation. Philadel-
phia: WB Saunders Company, 1993.
27. Emtner M, Porszasz J, Burns M, et al. Bene ts of supplemen-
tal oxygen in exercise training in nonhypoxemic chronic obstruc-
tive pulmonary disease patients. Am J Respir Crit Care Med
2003;168:1034—1042.
28. Markovitz GH, Cooper CB. Exercise and interstitial lung disease.
Curr Opin Pulm Med 1998;4:272—280.
29. Ekblom BT. Blood boosting and sport. Baillieres Best Pract Res
Clin Endocrinol Metab 2000;14:89—98.
30. Levine BD, Stray-Gundersen J. Living high-training low”: effect
of moderate-altitude acclimatization with low-altitude training on
performance. J Appl Physiol 1997;83:102—112.
31. Gaudard A, Varlet-Marie E, Bressolle F, et al. Drugs for increas-
ing oxygen and their potential use in doping: a review. Sports Med
2003;33:187—212.
32. Brittinger WD, Twittenhoff WD, Schwarzbeck A, et al. Haemo-
dynamic effects of A-V shunts and their clinical signi cance. Proc
Eur Dial Transplant Assoc 1972;9:642—649.
33. CooperC,GalindoJ,PosadasR,etal.Improvedexerciseperfor-
mance with supplemental oxygen predicts a bene cial response
to therapeutic arterio-venous stula in patients with severe COPD.
Chest 2007;132:453S.
COPD: Journal of Chronic Obstructive Pulmonary Disease December 2008 381